Pamela Samson

ORCID: 0000-0003-2448-2123
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Lung Cancer Treatments and Mutations
  • Cardiac Arrhythmias and Treatments
  • Esophageal Cancer Research and Treatment
  • Medical Imaging Techniques and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Cardiac pacing and defibrillation studies
  • Gastric Cancer Management and Outcomes
  • Glioma Diagnosis and Treatment
  • Cardiac Imaging and Diagnostics
  • Esophageal and GI Pathology
  • Radiation Therapy and Dosimetry
  • Brain Metastases and Treatment
  • Lung Cancer Research Studies
  • Cardiac electrophysiology and arrhythmias
  • Management of metastatic bone disease
  • Atrial Fibrillation Management and Outcomes
  • Radiation Dose and Imaging
  • Cancer Genomics and Diagnostics
  • Head and Neck Cancer Studies
  • Multiple and Secondary Primary Cancers
  • Advances in Oncology and Radiotherapy
  • Advanced X-ray and CT Imaging
  • Colorectal and Anal Carcinomas

Washington University in St. Louis
2016-2025

Washington University Medical Center
2018-2025

Alvin J. Siteman Cancer Center
2024

Barnes-Jewish Hospital
2016-2021

Jewish Hospital
2019-2020

Outcomes Research Consortium
2017

Webster Groves Nature Study Society
2016

NorthEast Regional Epilepsy Group
2016

Research Network (United States)
2016

Case studies have suggested the efficacy of catheter-free, electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia (VT) using stereotactic body radiation therapy, although prospective data are lacking.We conducted a phase I/II trial in adults with treatment-refractory episodes VT or cardiomyopathy related to premature contractions (PVCs). Arrhythmogenic scar regions were targeted by combining anatomic and electric imaging standard therapy workflow followed...

10.1161/circulationaha.118.038261 article EN Circulation 2019-01-14

Abstract Background Online adaptive stereotactic radiotherapy allows for improved target and organ at risk (OAR) delineation inter-fraction motion management via daily planning. The use of SBRT the treatment pancreatic cancer (performed until now using only MRI or CT on rails-guided radiotherapy), has yielded promising outcomes. Herein we describe first reported case cone beam CT-guided (CT-STAR) cancer. Case presentation A 61-year-old female with metastatic presented durable palliation a...

10.1186/s13014-022-02125-z article EN cc-by Radiation Oncology 2022-09-13

Introduction Bone metastases are associated with increased morbidity and decreased quality of life in patients solid tumors. Identifying at risk bone diagnosis could lead to earlier interventions. We sought retrospectively identify the incidence predictive factors for initial a large population-based dataset. Methods The Surveillance, Epidemiology, End Results (SEER) database was used 18 years-old or older diagnosed cancers from 2010 2019. Patients hematologic malignancies primary tumors...

10.3389/fonc.2024.1392667 article EN cc-by Frontiers in Oncology 2024-05-10

No AccessJournal of UrologyAdult Urology1 Feb 2018Treatment Patterns and Overall Survival Outcomes Octogenarians with Muscle Invasive Cancer the Bladder: An Analysis National Database Benjamin W. Fischer-Valuck, Yuan James Rao, Soumon Rudra, Daniel Przybysz, Elizabeth Germino, Pamela Samson, Brian C. Baumann, Hiram Gay, Jeff Michalski Fischer-ValuckBenjamin Fischer-Valuck More articles by this author , RaoYuan Rao RudraSoumon Rudra PrzybyszDaniel Przybysz GerminoElizabeth Germino...

10.1016/j.juro.2017.08.086 article EN The Journal of Urology 2017-08-24

Consolidation durvalumab improved overall survival (OS) in locally advanced non-small cell lung cancer (LA-NSCLC) treated with chemoradiotherapy (CRT) the PACIFIC trial; however, pneumonitis was increased durvalumab. We sought to examine real-world outcomes paradigm, especially factors associated pneumonitis, using a multi-institutional review.Patients LA-NSCLC CRT followed by from January 2017-February 2019 were identified at 2 institutions. characterized demographics, tumor factors,...

10.21037/jtd-20-1792 article EN Journal of Thoracic Disease 2020-11-01

Curative-intent radiotherapy plays an integral role in the treatment of lung cancer and therefore improving its therapeutic index is vital. MR guided (MRgRT) systems are latest technological advance which may help with achieving this aim. The majority MRgRT treatments delivered to date have been stereotactic body radiation therapy (SBRT) based include (ultra-) central tumors. However, there a move also implement as curative-intent for patients inoperable locally advanced NSCLC. This paper...

10.3389/fonc.2021.617681 article EN cc-by Frontiers in Oncology 2021-03-10
Coming Soon ...